REAL-WORLD TREATMENT ADHERENCE AND OVERALL SURVIVAL IN CANCER PATIENTS RECEIVING PEMBROLIZUMAB THROUGH A PATIENT ASSISTANCE PROGRAM AT MILITARY HOSPITAL 175. YHCĐ. 2026;67(Số CĐ12- Bệnh viện Ung bướu Nghệ An). doi:10.52163/yhc.v67iCD12.6167